Lack of clinical significance of early ischemic changes on computed tomography in acute stroke.

CONTEXT The prevalence and clinical significance of early ischemic changes (EICs) on baseline computed tomography (CT) scan of the head obtained within 3 hours of ischemic stroke are not established. OBJECTIVE To determine the frequency and significance of EIC on baseline head CT scans in the National Institute of Neurological Disorders and Stroke (NINDS) rt-PA (recombinant tissue plasminogen activator) Stroke Trial. DESIGN AND SETTING The original study, a randomized controlled trial, took place from January 1991 through October 1994 at 43 sites, during which CT images were obtained within 3 hours of symptom onset and prior to the initiation of rt-PA or placebo. For the current analysis, detailed reevaluation was undertaken after October 1994 of all baseline head CT scans with clinical data available pretreatment (blinded to treatment arm). PATIENTS Of 624 patients enrolled in the trial, baseline CT scans were retrieved and reviewed for 616 (99%). MAIN OUTCOME MEASURES Frequency of EICs on baseline CT scans; association of EIC with other baseline variables; effect of EICs on deterioration at 24 hours (>/=4 points increase from the baseline National Institutes of Health Stroke Scale [NIHSS] score); clinical outcome (measured by 4 clinical scales) at 3 months, CT lesion volume at 3 months, death at 90 days; and symptomatic intracranial hemorrhage (ICH) within 36 hours of treatment. RESULTS The prevalence of EIC on baseline CT in the combined rt-PA and placebo groups was 31% (n = 194). The EIC was significantly associated with baseline NIHSS score (rho = 0.23; P<.001) and time from stroke onset to baseline CT scan (rho = 0.11; P =.007). After adjusting for baseline variables, there was no EIC x treatment interaction detected for any clinical outcome, including deterioration at 24 hours, 4 clinical scales, lesion volume, and death at 90 days (P>/=.25), implying that EIC is unlikely to affect response to rt-PA treatment. After adjusting for NIHSS score (an independent predictor of ICH), no EIC association with symptomatic ICH at 36 hours was detected in the group treated with rt-PA (P>/=.22). CONCLUSIONS Our analysis suggests that EICs are prevalent within 3 hours of stroke onset and correlate with stroke severity. However, EICs are not independently associated with increased risk of adverse outcome after rt-PA treatment. Patients treated with rt-PA did better whether or not they had EICs, suggesting that EICs on CT scan are not critical to the decision to treat otherwise eligible patients with rt-PA within 3 hours of stroke onset.

[1]  L Bozzao,et al.  Early prediction of irreversible brain damage after ischemic stroke at CT. , 2001, Radiology.

[2]  Ninds,et al.  Effect of Intravenous Recombinant Tissue Plasminogen Activator on Ischemic Stroke Lesion Size Measured by Computed Tomography , 2000, Stroke.

[3]  A. Demchuk,et al.  Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy , 2000, The Lancet.

[4]  G. Albers,et al.  Intravenous tissue-type plasminogen activator for treatment of acute stroke: the Standard Treatment with Alteplase to Reverse Stroke (STARS) study. , 2000, JAMA.

[5]  R. Higashida,et al.  Intra-arterial Prourokinase for Acute Ischemic Stroke: The PROACT II Study: A Randomized Controlled Trial , 1999 .

[6]  G. Albers,et al.  Recombinant tissue-type plasminogen activator (Alteplase) for ischemic stroke 3 to 5 hours after symptom onset. The ATLANTIS Study: a randomized controlled trial. Alteplase Thrombolysis for Acute Noninterventional Therapy in Ischemic Stroke. , 1999, JAMA.

[7]  P D Lyden,et al.  Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. , 1999, Stroke.

[8]  Joseph P. Broderick,et al.  Effects of tissue plasminogen activator for acute ischemic stroke at one year , 1999 .

[9]  A. Fox,et al.  Evaluation of early computed tomographic findings in acute ischemic stroke. , 1999, Stroke.

[10]  M. Kaste,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) , 1998, The Lancet.

[11]  D L Schriger,et al.  Cranial computed tomography interpretation in acute stroke: physician accuracy in determining eligibility for thrombolytic therapy. , 1998, JAMA.

[12]  P Trouillas,et al.  Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. , 1998, Lancet.

[13]  L Bozzao,et al.  Acute stroke: usefulness of early CT findings before thrombolytic therapy. , 1997, Radiology.

[14]  N L Geller,et al.  Use of a global test for multiple outcomes in stroke trials with application to the National Institute of Neurological Disorders and Stroke t-PA Stroke Trial. , 1996, Stroke.

[15]  T Moulin,et al.  Early CT signs in acute middle cerebral artery infarction , 1996, Neurology.

[16]  L. Sayadi,et al.  Abstract , 1897, Journal of the Neurological Sciences.

[17]  Koroshetz Wj,et al.  Tissue plasminogen activator for acute ischemic stroke. , 1996, The New England journal of medicine.

[18]  Joseph P. Broderick,et al.  Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. , 1995 .

[19]  M. Kaste,et al.  Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS) , 1995, JAMA.

[20]  W. Yuh,et al.  Magnetic resonance versus computed tomographic imaging in acute stroke. , 1995, Stroke.

[21]  C. Manelfe,et al.  Early CT Diagnosis of Hemispheric Brain Infarction , 1995, Springer Berlin Heidelberg.

[22]  T. Brott,et al.  Improved Reliability of the NIH Stroke Scale Using Video Training , 1994, Stroke.

[23]  W Hacke,et al.  Sensitivity and prognostic value of early CT in occlusion of the middle cerebral artery trunk. , 1994, AJNR. American journal of neuroradiology.

[24]  L. Bozzao,et al.  Early angiographic and CT findings in patients with hemorrhagic infarction in the distribution of the middle cerebral artery. , 1991, AJNR. American journal of neuroradiology.

[25]  J L Zito,et al.  Computed Tomographic‐Angiographic Findings Within the First Five Hours of Cerebral Infarction , 1991, Stroke.

[26]  C. Truwit,et al.  Loss of the insular ribbon: another early CT sign of acute middle cerebral artery infarction. , 1990, Radiology.

[27]  D. Hosmer,et al.  Applied Logistic Regression , 1991 .

[28]  L Bozzao,et al.  Correlation of angiographic and sequential CT findings in patients with evolving cerebral infarction. , 1989, AJNR. American journal of neuroradiology.

[29]  J. Marler,et al.  Measurements of acute cerebral infarction: a clinical examination scale. , 1989, Stroke.

[30]  F. Hsieh,et al.  Sample size tables for logistic regression. , 1989, Statistics in medicine.

[31]  F. Shishido,et al.  Early CT finding in cerebral infarction: obscuration of the lentiform nucleus. , 1988, Radiology.

[32]  R. Bloch,et al.  Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.

[33]  R. Jeffrey,et al.  High frequency CT findings within 24 hours after cerebral infarction. , 1981, AJR. American journal of roentgenology.

[34]  R. Knill-Jones,et al.  Observer variability in assessing impaired consciousness and coma. , 1978, Journal of neurology, neurosurgery, and psychiatry.

[35]  M. Graffar [Modern epidemiology]. , 1971, Bruxelles medical.

[36]  F. Mahoney,et al.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX. , 2018, Maryland state medical journal.